Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride

IMPORTANCE: Glaucoma treatment has often been associated with adverse side‐effects from preservatives that are included in the used eye drops. BACKGROUND: To evaluate changes in the ocular surface and the presence of prostaglandin‐induced corneal disorders after being switched from latanoprost 0.005...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Tina T, Aung, Tin, Ho, Ching Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585858/
https://www.ncbi.nlm.nih.gov/pubmed/29802759
http://dx.doi.org/10.1111/ceo.13329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585858/
https://www.ncbi.nlm.nih.gov/pubmed/29802759
http://dx.doi.org/10.1111/ceo.13329

Ejemplares similares